The Earlier the Better: Probing Malignancies in Newborns
(L-R) Prof.Wolfgang Holzgreve, Prof. Marek Glazerman, Prof. Israel Meisner
Building on their established international partnership, GE Healthcare and Rabin Medical Center are developing innovative products and working on creative medical solutions to facilitate the early diagnosis of medical problems in pregnant women and their fetuses. An international data registry on fetal tumors is already in progress, which will assist in treating malignant conditions in both fetuses and newborns. Prof. Israel Meisner, head of RMC's Obstetric Ultrasound Unit, said tumors such as Neuroblastoma can be fully cured if discovered early in a fetus, and he believes this registry is important.
The data registry project was inaugurated during a conference at Rabin Medical Center on Women's Healthcare organized by GE Healthcare Israel, headed by Tony Bachar, and by the Rabin Medical Center's Women's Hospital, headed by Prof. Marek Glazerman. Among the honored guests present was Prof. Wolfgang Holzgreve, head of obstetrics and gynecology at the renowned University of Basel in Switzerland.
Related Articles
Genetic Testing: Fact and Fiction
One of the major roles of genetic testing
in today's modern world is to provide a
simple and easy method of diagnosing
genetic diseases in order to save lives.
Rabin Medical Center Saves Breast Cancer Patients with New Mammography Techniques
A researcher at Zebra Medical Vision has created a new mammography algorithm that uses machine and deep learning to diagnose breast cancer (BC), with results that the company claims are superior to those achieved using current methods.
Pain and the Relation to Treatment with Cannabis
50-80% of people with Parkinson's disease suffer from a specific type of pain, which until today has not been diagnosed and treated as a general part of this disease.